Brivaracetam
布瓦西坦
Report date: 2026/05/24 20:00:34
NME
Base Information
Drug NameBrivaracetam
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2016/01/13
Country/Territory +[47]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesUcb
China Registration ClassN/A
Develop Information
Active CompaniesJiangxi Kvvit Pharmaceutical Co LtdUcb Biopharma SrlUcb Inc +[11]
Inactive CompaniesOverseas Pharmaceuticals LtdUcb Biopharma SprlUcb Pharma +[6]
Active Indications +[10]
Inactive Indications